In this webinar, EMBL researchers discuss using CRISPR interference, coupled with targeted single-cell RNA sequencing with the BD Rhapsody HT Xpress System, to systematically perturb more than one thousand regulatory elements overlapping immune disease risk variants and directly measure their impact on candidate target genes and regulatory networks.